Infliximab treatment does not induce apoptosis in peripheral blood mononuclear cells up to 24 hours after initiation of treatment in rheumatoid arthritis patients

Míreanna Comhchosúla

• Infliximab treatment reduces synovial cellularity as early as 48 hours after initiation of treatment, but not by induction of apoptosis
  le: Smeets, TJM, et al.
  Foilsithe: (2003)
• Characterization of BDCA1 and BDCA4 dendritic cell subsets in rheumatoid arthritis patients
  le: Lebre, MC, et al.
  Foilsithe: (2004)
• Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis
  le: Haringman, J J, et al.
  Foilsithe: (2006)
• The Gene Expression Profile in the Synovium as a Predictor of the Clinical Response to Infliximab Treatment in Rheumatoid Arthritis
  le: Lindberg, Johan, et al.
  Foilsithe: (2010)
• Comparison of knee joints with small joints: implications for pathogenesis and evaluation of treatment in rheumatoid arthritis
  le: Kraan, MC, et al.
  Foilsithe: (2002)